About The Leukemia & Lymphoma Society
The journey of The Leukemia & Lymphoma Society (LLS) began not in a boardroom, but from the profound grief of a family. In 1944, the de Villiers family of New York experienced the devastating loss of their 16-year-old son, Robert, to leukemia. At a time when treatment options were scarce and the understanding of blood cancers was limited, their personal tragedy ignited a powerful resolve. Driven by the belief that these diseases were conquerable, Rudolph and Antoinette de Villiers established the Robert Roesler de Villiers Foundation in 1949. With a modest starting investment and a small group of dedicated volunteers operating from a small office in Manhattan, they laid the groundwork for what would become a global force in the fight against blood cancer. This nascent organization was fueled by an unwavering commitment to fund research and provide support to families grappling with similar heart-wrenching diagnoses.
As the years passed, the foundation evolved, mirroring the growing understanding of the diseases it sought to eradicate. In 1955, it became the Leukemia Society, and by the 1960s, it had expanded its reach across the nation, rebranding as The Leukemia Society of America to reflect its broader scope. A pivotal moment came in 2000 when the organization once again changed its name to The Leukemia & Lymphoma Society (LLS), a strategic move to underscore its dedication to combating all forms of blood cancer, including lymphoma, Hodgkin's disease, and myeloma. This evolution was more than just a name change; it signified a deeper commitment to a comprehensive mission encompassing research, patient support, education, and advocacy. Today, LLS stands as the world's largest voluntary health organization dedicated to blood cancer, having invested over $1.8 billion in cutting-edge research. From its humble beginnings born of personal loss, LLS has grown into a beacon of hope, relentlessly pursuing cures and improving the quality of life for countless patients and their families across the United States and Canada.
FAQs
- When was The Leukemia & Lymphoma Society founded?
- The Leukemia & Lymphoma Society was founded in 1949.
- Who is the CEO of The Leukemia & Lymphoma Society?
- E. Anders Kolb is the CEO.
- What industries or markets does The Leukemia & Lymphoma Society operate in?
- The Leukemia & Lymphoma Society operates in the following markets: Healthcare, Nonprofit Organizations, Medical Research, Oncology, Patient Advocacy, Public Health, Education, Philanthropy, Biotechnology, and Healthcare Support Services.
- How many employees does The Leukemia & Lymphoma Society have?
- The Leukemia & Lymphoma Society has 1001-5000 employees.
- Where does The Leukemia & Lymphoma Society have employees?
- The Leukemia & Lymphoma Society has employees in United States.
- Is The Leukemia & Lymphoma Society hiring?
- Yes, The Leukemia & Lymphoma Society has 3 open remote jobs.
- Does The Leukemia & Lymphoma Society support remote work or working from home?
- Yes, The Leukemia & Lymphoma Society is a remote-friendly company.
- What employee benefits does The Leukemia & Lymphoma Society offer?
- The Leukemia & Lymphoma Society provides 8 benefits to their employees.
- Does The Leukemia & Lymphoma Society offer a four-day work week?
- No, The Leukemia & Lymphoma Society does not offer a four-day work week.
- Is The Leukemia & Lymphoma Society transparent about salaries?
- Yes, The Leukemia & Lymphoma Society practices salary transparency, often including salary or compensation ranges in their job posts. They provide salary data for 11 roles.
- What is The Leukemia & Lymphoma Society's tech stack?
- The Leukemia & Lymphoma Society has 6 technologies in their tech stack.
- What is The Leukemia & Lymphoma Society's website?
- The Leukemia & Lymphoma Society's website is lls.org.
